UA124910U - METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE - Google Patents

METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE

Info

Publication number
UA124910U
UA124910U UAU201711312U UAU201711312U UA124910U UA 124910 U UA124910 U UA 124910U UA U201711312 U UAU201711312 U UA U201711312U UA U201711312 U UAU201711312 U UA U201711312U UA 124910 U UA124910 U UA 124910U
Authority
UA
Ukraine
Prior art keywords
postmenopause
treatment
cognitive disorders
discirculatory encephalopathy
biologically active
Prior art date
Application number
UAU201711312U
Other languages
Ukrainian (uk)
Inventor
Володимир Юрійович Прокопюк
Ірина Борисівна Мусатова
Олег Володимирович Чуб
Ольга Степанівна Прокопюк
Вікторія Василівна Воліна
Original Assignee
Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України filed Critical Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Priority to UAU201711312U priority Critical patent/UA124910U/en
Publication of UA124910U publication Critical patent/UA124910U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Спосіб лікування когнітивних порушень при дисциркуляторній енцефалопатії в постменопаузі включає використання біологічно активного препарату. Як біологічно активний препарат використовують кріоконсервований експлант плаценти, який вводять внутрішньом'язово в дозі, розрахованій у відповідності до маси тіла, двічі з інтервалом в 2 тижні.A method of treating cognitive impairment in postmenopausal dyscirculatory encephalopathy involves the use of a biologically active drug. As a biologically active drug is used cryopreserved placenta explant, which is administered intramuscularly at a dose calculated in accordance with body weight, twice every 2 weeks.

UAU201711312U 2017-11-20 2017-11-20 METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE UA124910U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201711312U UA124910U (en) 2017-11-20 2017-11-20 METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201711312U UA124910U (en) 2017-11-20 2017-11-20 METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE

Publications (1)

Publication Number Publication Date
UA124910U true UA124910U (en) 2018-04-25

Family

ID=62027503

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201711312U UA124910U (en) 2017-11-20 2017-11-20 METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE

Country Status (1)

Country Link
UA (1) UA124910U (en)

Similar Documents

Publication Publication Date Title
CO2019013707A2 (en) Aadc polynucleotides for the treatment of parkinson's disease
MX2021000071A (en) Use of pridopidine to improve cognitive function and for treating alzheimer's disease.
PH12017500843A1 (en) Methods for treating ocular diseases
MX2018005588A (en) Plasminogen replacement therapy for plasminogen-deficiency.
PH12020551425A1 (en) Rimegepant for cgrp related disorders
CL2018001677A1 (en) Treatment of fabry disease in patients not treated and previously treated with ert
MX2017010544A (en) Methods and compositions for treating dry eye disease and other eye disorders.
EA201992862A1 (en) Nasal Drug Forms of Dihydroergotamine
HRP20211824T1 (en) Modulators of complement activity
EP4324454A3 (en) Cross-linking agents and associated methods
MX2021002321A (en) Novel methods.
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
MX2022009736A (en) P2X<sub>3</sub> AND/OR P2X<sub>2/3</sub> COMPOUNDS AND METHODS.
MY199237A (en) Methods of treating ocular conditions
EA201891007A1 (en) AIMING FOR FORMILPEPTID RECEPTOR 2 / LIPOXIN A RECEPTOR (FPR2 / ALX) FOR TREATING HEART DISEASES
MX2021002322A (en) Novel methods.
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
MX2019006141A (en) Methods of treating inflammatory disorders with multivalent fc compounds.
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
PH12019501785A1 (en) Intranasal composition comprising betahistine
UA124910U (en) METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE
EA202091653A1 (en) MINOCYCLINE FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
PH12021550671A1 (en) Prodrugs of cgrp antagonists
EA201592058A1 (en) APPLICATION OF LANDIOLOL HYDROCHLORIDE IN LONG-TERM TREATMENT OF TACHIHARITHMIA
MX2020007627A (en) Use of carrimycin or active ingredient thereof.